Potential preventive and therapeutic effects of glutathione supplementation in experimental colitis

ABSTRACT

The aim of this study was to assess the potential preventive and therapeutic effects of glurathione [GSH] on inflammatory bowel diseases [IBD] and to evaluate the use of fecal calprotectin [FC] and fecal lactoferrjn [Lf] as a non-invasive diagnostic marker of IBD. Forty albino rats were divided into four groups; group I control group; group II acetic acid induced colitis group, group III after colitis induction, rats were treated with glutathione for one week [50 mg/kg, i.p.] and group IV before the induction of colitis, rats were given a preventive dose of glutathione [200 mg/kg, i.p]. At the end of experimental period, rats were sacrificed, fecal calprotectin and lactoferrin were assessed in the different groups, the level of antioxidants in the intestine was evaluated and the severity of inflammation was histopathologically scored. Intestinal glutathione level was decreased significantly after colitis induction, however, it was significantly high in the prevention group. There was significant reduction in the antioxidant enzymes after colitis induction. However, glutathione prevention was associated with higher antioxidant enzymes compared to treatment. Various histopathological changes as inflammation, ulceration and dysplasia were detected after colitis induction and in rats treated with glutathione, however, rats supplemented with glutathione as prevention showed no ulceration and mild inflammation. In addition, colitis induction was associated with significant increase in the colonic level of FC and Lf which was significantly reduced with glutathione prevention. Glutathione prevention appeared to be beneficial for the acute stage of IBD than glurathione treatment. Moreover, intestinal antioxidant enzymes were correlated negatively with FC level. FC and Lf can be used as non-invasive and simple marker for diagnosis of IBD